CGA
ORCL icon

Crescent Grove Advisors’s Oracle ORCL Stock Holding History

Crescent Grove Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,137
Closed -$268K – 309
2024
Q1 		$268K Hold
2,137
– – 0.03% 257
2023
Q4 		$225K Buy
+2,137
New +$233K 0.03% 268
2023
Q3 		– Sell
-1,722
Closed -$205K – 294
2023
Q2 		$205K Buy
+1,722
New +$178K 0.02% 279
2019
Q1 		– Sell
-5,619
Closed -$254K – 165
2018
Q4 		$254K Buy
+5,619
New +$269K 0.05% 133
2018
Q2 		– Sell
-6,000
Closed -$275K – 148
2018
Q1 		$275K Hold
6,000
– – 0.07% 112
2017
Q4 		$284K Hold
6,000
– – 0.07% 106
2017
Q3 		$290K Hold
6,000
– – 0.07% 106
2017
Q2 		$301K Buy
+6,000
New +$273K 0.09% 99

Other funds holding ORCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Crescent Grove Advisors's ORCL Position: Q2 2024 in Review

Crescent Grove Advisors sold out of Oracle (ORCL) in Q2 2024, closing a stake of 2,137 shares — an estimated $268K sold.

Crescent Grove Advisors first reported a position in ORCL in Q2 2017 and held it in 8 quarters. The position peaked at $301K in Q2 2017. 2,915 funds tracked by Wall St. Rank hold ORCL as of Q2 2024.

  • Crescent Grove Advisors reported no remaining Oracle position as of Q2 2024 after selling out during the quarter.
  • Crescent Grove Advisors sold 2,137 Oracle shares in Q2 2024, an estimated $268K.
  • Crescent Grove Advisors first reported a position in Oracle in Q2 2017 and held it in 8 quarters.
  • Crescent Grove Advisors's Oracle position peaked at $301K in Q2 2017.
  • 2,915 funds tracked by Wall St. Rank held Oracle as of Q2 2024.

Based on Crescent Grove Advisors's 13F filing for Q2 2024, filed 22 Jul 2024.